Advantages and limitations of mouse models to deplete dendritic cells

European Journal of Immunology

Volumn 43, Issue 1, 2013, Pages 22-26

  Van Blijswijk, Janneke ^a   Schraml, Barbara U ^a   Sousa, Caetano Reis e ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Dendritic cells; Diphtheria toxin; Langerhans cells; Monocytosis; Neutrophilia

Indexed keywords

GLYCOPROTEIN P 15095;

CD8+ T LYMPHOCYTE; CELL POPULATION; DENDRITIC CELL; HUMAN; IMMUNOCOMPETENT CELL; MACROPHAGE; MONOCYTE; NATURAL KILLER CELL; NONHUMAN; NOTE; PLASMABLASTIC LYMPHOMA; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD11C; DENDRITIC CELLS; DIPHTHERIA TOXIN; HUMANS; IMMUNITY, INNATE; MICE; MICE, TRANSGENIC; MODELS, ANIMAL; MONOCYTES; NEUTROPHILS; PROMOTER REGIONS, GENETIC;

EID: 84872434125     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201243022     Document Type: Note

References (34)

1. Geissmann, F., Manz, M. G., Jung, S., Sieweke, M. H., Merad, M. and Ley, K., Development of monocytes, macrophages, and dendritic cells. Science 2010. 327: 656-661.
2. Hashimoto, D., Miller, J. and Merad, M., Dendritic cell and macrophage heterogeneity in vivo. Immunity 2011. 35: 323-335.
3. Heath, W. R. and Carbone, F. R., Dendritic cell subsets in primary and secondary T cell responses at body surfaces. Nat. Immunol. 2009. 10: 1237-1244.
4. Steinman, R. M. and Idoyaga, J., Features of the dendritic cell lineage. Immunol. Rev. 2010. 234: 5-17.
5. Merad, M., Manz, M. G., Karsunky, H., Wagers, A., Peters, W., Charo, I., Weissman, I. L. et al., Langerhans cells renew in the skin throughout life under steady-state conditions. Nat. Immunol. 2002. 3: 1135-1141.
6. + T cells by exogenous cell-associated antigens. Immunity 2002. 17: 211-220.
7. + T cells. J. Immunol. 2005. 175: 6428-6435.
8. Bogunovic, M., Ginhoux, F., Wagers, A., Loubeau, M., Isola, L. M., Lubrano, L., Najfeld, V. et al., Identification of a radio-resistant and cycling dermal dendritic cell population in mice and men. J. Exp. Med. 2006. 203: 2627-2638.
9. Hochweller, K., Striegler, J., Hammerling, G. J. and Garbi, N., A novel CD11c.DTR transgenic mouse for depletion of dendritic cells reveals their requirement for homeostatic proliferation of natural killer cells. Eur. J. Immunol. 2008. 38: 2776-2783.
10. Probst, H. C., Tschannen, K., Odermatt, B., Schwendener, R., Zinkernagel, R. M. and Van Den Broek, M., Histological analysis of CD11c-DTR/GFP mice after in vivo depletion of dendritic cells. Clin. Exp. Immunol. 2005. 141: 398-404.
11. Iannacone, M., Moseman, E. A., Tonti, E., Bosurgi, L., Junt, T., Henrickson, S. E., Whelan, S. P. et al., Subcapsular sinus macrophages prevent CNS invasion on peripheral infection with a neurotropic virus. Nature 2010. 465: 1079-1083.
12. Meredith, M. M., Liu, K., Darrasse-Jeze, G., Kamphorst, A. O., Schreiber, H. A., Guermonprez, P., Idoyaga, J. et al., Expression of the zinc finger transcription factor zDC (Zbtb46, Btbd4) defines the classical dendritic cell lineage. J. Exp. Med. 2012. 209: 1153-1165.
13. Satpathy, A. T., Albring, J. C., Edelson, B. T., Kretzer, N. M., Bhattacharya, D., Murphy, T. L. et al., Zbtb46 expression distinguishes classical dendritic cells and their committed progenitors from other immune lineages. J. Exp. Med. 2012. 209: 1135-1152.
14. Bennett, C. L., van Rijn, E., Jung, S., Inaba, K., Steinman, R. M., Kapsenberg, M. L. and Clausen, B. E., Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity. J. Cell Biol. 2005. 169: 569-576.
15. Kissenpfennig, A., Henri, S., Dubois, B., Laplace-Builhe, C., Perrin, P., Romani, N., Tripp, C. H. et al., Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity 2005. 22: 643-654.
16. + dendritic cells. J. Exp. Med. 2007. 204: 3147-3156.
17. Kautz-Neu, K., Noordegraaf, M., Dinges, S., Bennett, C. L., John, D., Clausen, B. E. and von Stebut, E., Langerhans cells are negative regulators of the anti-Leishmania response. J. Exp. Med. 2011. 208: 885-891.
18. Kaplan, D. H., Jenison, M. C., Saeland, S., Shlomchik, W. D. and Shlomchik, M. J., Epidermal langerhans cell-deficient mice develop enhanced contact hypersensitivity. Immunity 2005. 23: 611-620.
19. + T cell accrual. Immunity 2010. 33: 955-966.
20. Takagi, H., Fukaya, T., Eizumi, K., Sato, Y., Sato, K., Shibazaki, A., Otsuka, H. et al., Plasmacytoid dendritic cells are crucial for the initiation of inflammation and T cell immunity in vivo. Immunity 2011. 35: 958-971.
21. Zhang, J., Raper, A., Sugita, N., Hingorani, R., Salio, M., Palmowski, M. J., Cerundolo, V. et al., Characterization of Siglec-H as a novel endocytic receptor expressed on murine plasmacytoid dendritic cell precursors. Blood 2006. 107: 3600-3608.
22. Blasius, A. L., Cella, M., Maldonado, J., Takai, T. and Colonna, M., Siglec-H is an IPC-specific receptor that modulates type I IFN secretion through DAP12. Blood 2006. 107: 2474-2476.
23. + dendritic cells mediate the development of experimental cerebral malaria. J. Immunol. 2012. 189: 1128-1132.
24. Poulin, L. F., Reyal, Y., Uronen-Hansson, H., Schraml, B. U., Sancho, D., Murphy, K. M., Hakansson, U. K. et al., DNGR-1 is a specific and universal marker of mouse and human Batf3-dependent dendritic cells in lymphoid and nonlymphoid tissues. Blood 2012. 119: 6052-6062.
25. Caminschi, I., Proietto, A. I., Ahmet, F., Kitsoulis, S., Shin Teh, J., Lo, J. C., Rizzitelli, A. et al., The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement. Blood 2008. 112: 3264-3273.
26. Sancho, D., Mourão-Sá, D., Joffre, O. P., Schulz, O., Rogers, N. C., Pennington, D. J., Carlyle, J. R. et al., Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin. J. Clin. Invest. 2008. 118: 2098-2110.
27. + conventional dendritic cells impacts the regulation of T-cell immunity and homeostasis in vivo. Proc. Natl. Acad. Sci. USA 2012. 109: 11288-11293.
28. + dendritic cells are the critical source of interleukin-12 that controls acute infection by Toxoplasma gondii tachyzoites. Immunity 2011. 35: 249-259.
29. + dendritic cells in cytotoxic T cell immunity. Science 2008. 322: 1097-1100.
30. Tittel, A. P., Heuser, C., Ohliger, C., Llanto, C., Yona, S., Hammerling, G. J., Engel, D. R. et al., Functionally relevant neutrophilia in CD11c diphtheria toxin receptor transgenic mice. Nat. Methods 2012. 9: 385-390.
31. Birnberg, T., Bar-On, L., Sapoznikov, A., Caton, M. L., Cervantes-Barragán, L., Makia, D., Krauthgamer, R. et al., Lack of conventional dendritic cells is compatible with normal development and T cell homeostasis, but causes myeloid proliferative syndrome. Immunity 2008. 29: 986-997.
32. Ohnmacht, C., Pullner, A., King, S. B. S., Drexler, I., Meier, S., Brocker, T. and Voehringer, D., Constitutive ablation of dendritic cells breaks self-tolerance of CD4 T cells and results in spontaneous fatal autoimmunity. J. Exp. Med. 2009. 206: 549-559.
33. Autenrieth, S. E., Warnke, P., Wabnitz, G. H., Lucero Estrada, C., Pasquevich, K. A., Drechsler, D., Gunter, M. et al., Depletion of dendritic cells enhances innate anti-bacterial host defense through modulation of phagocyte homeostasis. PLoS Pathog. 2012. 8: e1002552.
34. Ciavarra, R. P., Stephens, A., Nagy, S., Sekellick, M. and Steel, C., Evaluation of immunological paradigms in a virus model: are dendritic cells critical for antiviral immunity and viral clearance? J. Immunol. 2006. 177: 492-500.